Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: NVAX stock price vs LYFT: inconclusive — current versus $6.33 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LYFT's multiple
Implied fair value · at NVAX's multiple
Needs NVAX P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: NVAX FY 2025 (ended Dec 31, 2025) · LYFT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 85% equity / 15% debt · EV / Revenue 0.89x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
NOVAVAX INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Lyft, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-2.76x
0.34x
Net debt / EBITDA
Leverage against operating earnings
-0.84x
57.19x
Cash and equivalents
Liquid reserves on the balance sheet
$735.08M
$1.84B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Moderna, Inc.
NVAX vs MRNA
BioNTech SE
NVAX vs BNTX
Emergent BioSolutions Inc.
NVAX vs EBS
ASTRAZENECA PLC
NVAX vs AZN
GSK plc
NVAX vs GSK
Uber Technologies, Inc
NVAX vs UBER
Airbnb, Inc.
NVAX vs ABNB
Booking Holdings Inc.
NVAX vs BKNG
DoorDash, Inc.
NVAX vs DASH
Grab Holdings Ltd
NVAX vs GRAB
TaskUs, Inc.
NVAX vs TASK
$353.17M
$1.10B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
